Singapore-based investment Temasek infuses over Rs 690 crore in Molbio Diagnostics

New Delhi: Healthcare solutions provider Molbio Diagnostics on Monday said Singapore-based investment firm Temasek has invested USD 85 million (over Rs 690 crore) in the company. Goa-based Molbio...

Related Keywords

India ,Ceo Sriram Natarajan ,Rohit Mantri ,Union Territories ,National Tuberculosis Elimination Program ,Temasek ,Motilal Oswal Alternates ,Molbio Diagnostics ,Diagnostics Director ,Msriram Natarajan ,Oswal Alternates Director Rohit Mantri ,Oswal Alternates ,Molbio Diagnostics News ,Investment , ,